Innovatus Life Sciences Acquisition Corp. New York, New York 10017Innovatus Life Sciences Acquisition Corp. • March 5th, 2021 • Blank checks • New York
This agreement (the “Agreement”) is entered into on the date hereof by and between Innovatus Life Sciences Acquisition Sponsor, LLC, a Delaware limited liability company (the “Subscriber” or “you”) and Innovatus Life Sciences Acquisition Corp., a Delaware corporation (the “Company”, “we” or “us”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 5,031,250 shares of Class B common stock, $0.0001 par value per share (the “Shares”), up to 656,250 of which are subject to forfeiture by you if the underwriters of the initial public offering (“IPO”) of shares of Class A common stock of the Company, do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company and the Subscriber’s agreements regarding such Shares are as follows:
